RE: It’s not over til it’s over.9 Feb 2021 22:35
Bertie
All the very best. I was waiting fir the sp to fall back to the 10s before buying. Thankfully the RNS dropped so it saved me having to make the decision.
I actually thought the delay was down to a NDC for a discussion on a takeover but not agreeing the trial design was not expected.
Fwiw, I do think Lupuzor will come to the market. The safety record and crossover possibilities are too compelling to be ignored. The gamble is who holds the rights to profit from it.
By the way, contrary to some posters view, IMM is not a one trick pony. However, they have to start realising shareholders need to be recognised and not being thought of as a distraction from the science.
I have followed the journey of this company since 2007 and it has served me well but the focus has to be shifted away from the arrogance and egos of a select few board members.